ATON Key Statistics, Chart & Performance
The current stock price of ATON is 2.12 USD. In the past month the price decreased by -58.33%.
ATON Latest News, Press Relases and Analysis
ATON Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.15 | 403.16B | ||
| AMGN | AMGEN INC | 15.58 | 183.49B | ||
| GILD | GILEAD SCIENCES INC | 15.44 | 156.91B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.72 | 110.01B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.32 | 82.62B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 850.94 | 56.89B | ||
| INSM | INSMED INC | N/A | 43.60B | ||
| NTRA | NATERA INC | N/A | 32.97B | ||
| BIIB | BIOGEN INC | 10.84 | 26.61B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.38 | 21.94B | ||
| INCY | INCYTE CORP | 16.49 | 20.67B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.20B |
Related stock screener links
About ATON
Company Profile
AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. The firm is focused on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The firm implements a treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, the Company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. The company is also advancing therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The firm engages in the drug development process and provides strategic counsel to guide development of immunotherapy assets and asset combinations.
Company Info
ALPHATON CAPITAL CORP
Clarence Thomas Building, P.O. Box 4649, Road Town
Tortola ONTARIO VG
Employees: 3
Phone: 4167377600
ALPHATON CAPITAL CORP / ATON FAQ
What does ATON do?
AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. The firm is focused on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The firm implements a treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, the Company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. The company is also advancing therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The firm engages in the drug development process and provides strategic counsel to guide development of immunotherapy assets and asset combinations.
Can you provide the latest stock price for ALPHATON CAPITAL CORP?
The current stock price of ATON is 2.12 USD. The price decreased by -1.4% in the last trading session.
Does ATON stock pay dividends?
ATON does not pay a dividend.
What is the ChartMill rating of ALPHATON CAPITAL CORP stock?
ATON has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is ALPHATON CAPITAL CORP worth?
ALPHATON CAPITAL CORP (ATON) has a market capitalization of 13.46M USD. This makes ATON a Nano Cap stock.
Can you provide the upcoming earnings date for ALPHATON CAPITAL CORP?
ALPHATON CAPITAL CORP (ATON) will report earnings on 2025-12-01.
ATON Technical Analysis
ATON Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ATON. Both the profitability and financial health of ATON have multiple concerns.
ATON Financial Highlights
Over the last trailing twelve months ATON reported a non-GAAP Earnings per Share(EPS) of -5.72. The EPS increased by 92.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -304.13% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |